1. Novartis Reports Results of Enerzair Breezhaler (QVM149) in P-IIIb ARGON Study to Treat Uncontrolled Asthma

Published: Jun 04, 2020 | Tags: Novartis, Reports, Enerzair Breezhaler, QVM149, P-IIIb, ARGON Study, Treat, Uncontrolled Asthma

2. Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals

Published: Jun 04, 2020 | Tags: Melinta Therapeutics, Acquire, Tetraphase Pharmaceuticals

3. AstraZeneca Signs an Agreement with Serum Institute to Supply 1B Doses of Oxford University’s COVID-19 Vaccine

Published: Jun 04, 2020 | Tags: AstraZeneca, Collaborates, CEPI, GAVI, SII, Equitable Access,Oxford University’s COVID-19 Vaccine

4. Roche’s Elecsys IL-6 Test Receives the US FDA’s EUA to Identify Patients at High Risk of Severe Inflammatory Response with COVID-19

Published: Jun 04, 2020 | Tags: Roche, Elecsys IL-6 Test, Receives, US, FDA, EUA, Identify Patients, High Risk,  Severe Inflammatory Response, COVID-19

5. AstraZeneca Signs Exclusive Worldwide License Agreement with Accent for RMP-Targeting Therapies

Published: Jun 03, 2020 | Tags: Accent, Signs, Exclusive, Worldwide, License Agreement, AstraZeneca, RMP-Targeting Therapies

6. Mylan and Lupin Receive EC’s MAA for Nepexto (biosimilar, etanercept)

Published: Jun 04, 2020 | Tags: Mylan, Lupin, Receive, EC, MAA ,Nepexto, biosimilar, etanercept

7. Fresenius Kabi Reports the US FDA’s Acceptance of BLA for its MSB11455 (biosimilar, pegfilgrastim)

Published: Jun 04, 2020 | Tags: Fresenius Kabi, Reports, US, FDA, Acceptance, BLA, MSB11455, biosimilar, pegfilgrastim

8. Inovio to Initiate P-I/II Study of INO-4800 Against COVID-19 in South Korea

Published: Jun 03, 2020 | Tags: Inovio, Initiate, P-I/II, Study, INO-4800, Against, COVID-19, South Korea

9. Y-mAbs Reports the US FDA’s Acceptance of Priority Review for Danyelza’s (naxitamab) BLA to Treat Neuroblastoma

Published: Jun 03, 2020 | Tags: Y-mAbs, Reports, US, FDA, Acceptance, Priority Review, Danyelza, naxitamab, BLA, Treat, Neuroblastoma

10. Intravacc and EpiVax Collaborate to Develop an Emerging Vaccine for COVID-19

Published: Jun 02, 2020 | Tags: Intravacc, EpiVax, Collaborate, Develop, Emerging Vaccine, COVID-19

11. Eli Lilly to Present Data of Taltz (ixekizumab) for Patients with Psoriatic Arthritis at EULAR 2020 #EULAR

Published: Jun 03, 2020 | Tags: Eli Lilly, Present Data, Taltz, ixekizumab, Patients,  Psoriatic Arthritis, EULAR 2020, #EULAR

12. Lilly Reveals New Data for Olumiant (baricitinib) to Treat Rheumatoid Arthritis and Systemic Lupus Erythematosus #EULAR

Published: Jun 03, 2020 | Tags: Lilly, Reveals, New Data, Olumiant, baricitinib, Treat, Rheumatoid Arthritis, Systemic Lupus Erythematosus, #EULAR

13. Celltrion Anticipates the Launch of Insulin Pen Biosimilar by 2025

Published: Jun 03, 2020 | Tags: Celltrion, Anticipates, Launch, Insulin Pen, Biosimilar, 2025

14. Personalis Collaborates with Sarepta Therapeutics on Immune Response to Precision Genetic Therapeutics

Published: Jun 03, 2020 | Tags: Personalis, Collaborates, Sarepta Therapeutics, Immune Response, Precision Genetic Therapeutics

15. The US FDA Extends Review of sBLA of Ofatumumab (OMB157) for Patients with Relapsing Multiple Sclerosis

Published: Jun 03, 2020 | Tags: US, FDA, Extends, Review, sBLA, Ofatumumab, OMB157, Patients, Relapsing Multiple Sclerosis

16. Henlius and Accord Receive CHMP’s Positive Opinion for its HLX02 (biosimilar, trastuzumab)

Published:  Jun 02, 2020 | Tags: Henlius, Accord, Receive, CHMP, Positive Opinion, HLX02, biosimilar, trastuzumab

17. Revance and Mylan to Advance Development Program for a Proposed Biosimilar to BOTOX

Published: Jun 02, 2020 | Tags: Revance, Mylan, Advance, Development Program, Proposed Biosimilar, BOTOX

18. Roche’s Tecentriq + Avastin Receives the US FDA’s Approval for Unresectable or Metastatic Hepatocellular Carcinoma

Published: Jun 02, 2020 | Tags: Roche, Tecentriq, Avastin, Receive, US, FDA, Approval, Unresectable, Metastatic, Hepatocellular Carcinoma

19. Sanofi’s Sarclisa (isatuximab) Receives EC’s Approval for adults with Relapsed and Refractory Multiple Myeloma

Published: Jun 01, 2020 | Tags: Sanofi, Sarclisa, isatuximab, Receives, EC, Approval, Adults, Relapsed, Refractory, Multiple Myeloma

20. Regeneron and Intellia Expand Their 2016 Collaboration to Develop CRISPR/CAS9 Based Therapies

Published: Jun 02, 2020 | Tags: Regeneron, Intellia, Expand, 2016, Collaboration, Develop, CRISPR/CAS9 Based Therapies

21. Eli Lilly Initiates the World’s First Clinical Study to Evaluate the Potential of COVID-19 Antibody Treatment in Humans

Published: Jun 02, 2020 | Tags: Eli Lilly, Initiates, World, First, Clinical Study, Evaluate, Potential, COVID-19, Antibody, Treatment, Humans

22. AstraZeneca and Daiichi Sankyo Provide Updates of Enhertu (fam-trastuzumab deruxtecan-nxki) in HER2-Positive Metastatic Colorectal Cancer and HER2-Mutant Non-Small Cell Lung Cancer #ASCO20

Published:  May 29, 2020 | Tags:  AstraZeneca, Daiichi Sankyo, Enhertu, fam-trastuzumab deruxtecan-nxki, HER2-Positive, Metastatic Colorectal Cancer, HER2-Mutant, Non-Small Cell Lung Cancer, #ASCO20

23. AstraZeneca Reports Results of Tagrisso (osimertinib) in P-III ADAURA study for EGFR-Mutated Lung Cancer #ASCO20

Published: May 29, 2020 | Tags: AstraZeneca, Reports, Results, Tagrisso, osimertinib, P-III, ADAURA, Study, EGFR-Mutated Lung Cancer

24. Takeda to Present Results of Iclusig (ponatinib) in P-II OPTIC Study for Chronic Myeloid Leukemia in the Chronic Phase at ASCO and EHA #ASCO20

Published: Jun 01, 2020 | Tags: Takeda, Present, Results, Iclusig, ponatinib, P-II, OPTIC Study, Chronic Myeloid Leukemia, Chronic Phase, ASCO, EHA, #ASCO20

25. Merck’s Reports Results of Keytruda (pembrolizumab) in P-III KEYNOTE-177 for Patients with MSI-H Colorectal Cancer #ASCO20

Published: May 29, 2020 | Tags: Merck, Report, Result, Keytruda, (pembrolizumab), P-III, KEYNOTE-177, Patients, MSI-H Colorectal Cancer, #ASCO20

26. Seattle Genetics Report Updated Results of Tukysa (tucatinib) in HER2CLIMB Study for Patients with HER2-Positive Breast Cancer with Stable or Active Brain Metastases #ASCO20

Published: May 26, 2020 | Tags: Seattle Genetics, Report, Updated Results, Tukysa (tucatinib),  HER2CLIMB Study, HER2-Positive Breast Cancer, Stable, Active, Brain Metastases, #ASCO20

27. Merck KGaA and Pfizer’s Bavencio (avelumab) Demonstrates the Potential in Gestational Trophoblastic Tumors #ASCO20

Published: May 29, 2020 | Tags: Merck KGaA, Pfizer, Demonstrates, Potential, Bavencio, Avelumab, Gestational Trophoblastic Tumors, ASCO20

28. AbbVie Signs a Worldwide License Agreement with Jacobio to Advance SHP2 Inhibitors

Published: May 29, 2020 | Tags: AbbVie, Signs, Worldwide, License Agreement, Jacobio, Advance, SHP2 Inhibitors

29. Amgen Reports Clinical Data of AMG 510 in CodeBreaK 100 Study for Multiple Solid Tumors #ASCO20

Published: May 29, 2020 | Tags: Amgen, Reports, Clinical Data, AMG 510, CodeBreaK 100, Study, Multiple Solid Tumors, #ASCO20